In the third quarter of 2011, biopharma start-ups raised $299 million – $48 million more than last quarter, with more than half of the funding going to Series A rounds. (See Exhibit 1.)Medical device start-ups raised $134 million, up 19% from Q2. After two completely dry quarters in vitro diagnostics got on the board, but barely: two companies raised just $10 million combined in Series B funding – Quanterix Corp.[See Deal] and VitaPath Genetics Inc.[See Deal]
Exhibit 1
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?